Takeaway: We are removing DVA from the short side of Investing Ideas today.

A quick note from Hedgeye CEO Keith McCullough:

Post Chanos giving me an out, I’ll take even money on this one and wait to re-load on the next squeeze. From a quantitative signaling #process perspective, DVA is still Bullish @Hedgeye TREND. 

***No change to Healthcare analyst Tom Tobin's fundamental short thesis on DaVita (DVA). Click here to read our analyst's original report.